The adoption of HB 1338 is expected to have a significant impact on state laws regulating occupational licenses, as it overrides existing limitations that have historically made it difficult for individuals licensed out-of-state to practice in Illinois. The Act establishes that applicants must meet certain criteria, such as holding a valid occupational license for at least one year and not having a disqualifying criminal record. This change is anticipated to promote a more inclusive approach to professional mobility and could help retain skilled workers within the state, addressing gaps in labor markets.
Summary
House Bill 1338, titled the Universal Recognition of Occupational Licenses Act, seeks to streamline the process for individuals to obtain occupational licenses in Illinois by recognizing licenses or certifications from other states. This bill allows state boards to issue licenses or certifications to applicants who hold valid licenses in other states and those with relevant work experience, thereby facilitating easier entry into professions regulated by state laws. The Act is intended to enhance mobility for professionals and fill labor shortages by reducing barriers to entry for qualified individuals.
Contention
While the bill aims to facilitate the recognition of occupational licenses from other states, points of contention may arise around the standards of licensure. Opponents might argue that the Act could lower professional standards or lead to individuals with insufficient training being authorized to practice in Illinois. Additionally, there may be concerns regarding the adequacy of oversight by state boards, especially in professions where public safety is paramount. The implications for existing license holders and the potential impact on local educational and training programs could also be topics of debate amongst stakeholders.
Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.